Stock picking
McDonald’s in, Netflix out: The new face of Magellan reveals her picks
Magellan’s global equity fund, co-managed by Nikki Thomas, will be a key influence on whether the embattled money manager can turn things around.
- by Clancy Yeates
Latest
The long and short of it
Investing
Shares take a hit, but is CSL still a good growth opportunity?
The nation’s most well-known biotech export is focused well beyond the pandemic, a period that gave it the kind of exposure money can’t buy.
- by Emma Koehn
Analysis
Bubs Australia
Biden-approved: Should you invest in baby formula maker Bubs Australia?
Infant formula maker Bubs Australia has seen its share price soar since revealing a landmark US distribution deal, but does that make it a good investment?
- by Jessica Yun
Will climate change rout Warren Buffett’s bet on IAG?
The company behind some big insurance brands, including NRMA and SGIO, was once seen as a market darling, but it has underperformed markedly recently amid growing concerns about climate change risks.
- by Clancy Yeates
The long and short of it
Moderna
Is Dolly Parton-backed biotech Moderna a good investment?
It’s the global vaccine maker that has delivered huge returns for early backers, but can Moderna continue its growth in a post-COVID world?
- by Emma Koehn
Bell Potter faces AUSTRAC probe over anti-money laundering compliance
The financial crimes watchdog has ordered external auditors to look into concerns the stockbroker may not be complying with anti-money laundering laws.
- by Charlotte Grieve
Exclusive
Jane Hume
Bell Potter warns retail investors will pay the price for ‘heavy-handed’ stockbroking test
Investment house Bell Potter has attacked a new compliance test, claiming it is biased against stockbrokers and will push up costs for retail investors.
- by Charlotte Grieve
Minister defends controversial ethics test for stockbrokers
Minister for Financial Services Jane Hume has said the exam is designed to test competency, not expand skillsets.
- by Charlotte Grieve
Exclusive
Regulation
‘Failure rate is going through the roof’: Stockbrokers rail against mandatory compliance test
Some of the nation’s most prominent stockbroking firms are railing against a mandatory test they said is misguided and discriminates against experienced professionals.
- by Charlotte Grieve
Longstanding AMP investor decries ‘pretty woeful’ performance after selling out
AMP’s share price is more than 158 per cent lower than when it was first listed on the ASX in 1999. Argo Investments has had enough.
- by Charlotte Grieve